Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mario Venditti and Gabriella d'Ettorre.
Mario Venditti
Connection Strength
1.145
Gabriella d'Ettorre
  1. The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
    View in: PubMed
    Score: 0.234
  2. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
    View in: PubMed
    Score: 0.231
  3. Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization. Infez Med. 2020 Dec 01; 28(4):534-538.
    View in: PubMed
    Score: 0.229
  4. Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
    View in: PubMed
    Score: 0.227
  5. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
    View in: PubMed
    Score: 0.058
  6. Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
    View in: PubMed
    Score: 0.056
  7. Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
    View in: PubMed
    Score: 0.055
  8. Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.